These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26452467)

  • 1. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
    Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
    J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
    Grandgirard D; Schürch C; Cottagnoud P; Leib SL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis.
    Vivas M; Force E; Tubau F; El Haj C; Ariza J; Cabellos C
    Int J Antimicrob Agents; 2015 Jul; 46(1):28-32. PubMed ID: 25813395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
    Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
    J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
    J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
    Stucki A; Cottagnoud M; Winkelmann V; Schaffner T; Cottagnoud P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2249-52. PubMed ID: 17371817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model.
    Klein M; Höhne C; Angele B; Högen T; Pfister HW; Tüfekci H; Koedel U
    Clin Microbiol Infect; 2019 Jan; 25(1):108.e9-108.e15. PubMed ID: 29649601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of blood brain barrier integrity and modulation of inflammatory mediators during treatment of pneumococcal meningitis with daptomycin or ceftriaxone.
    Barichello T; Goncalves JC; Generoso Jda S; Simoes LR; Tashiro MH; Goularte Jde A; Vuolo F; Rodrigues DH; Vilela MC; Petronilho F; Teixeira AL; Quevedo J
    Curr Neurovasc Res; 2014; 11(3):210-22. PubMed ID: 24845856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis.
    Grandgirard D; Oberson K; Bühlmann A; Gäumann R; Leib SL
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1323-6. PubMed ID: 20065062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.
    Cabellos C; Martinez-Lacasa J; Martos A; Tubau F; Fernández A; Viladrich PF; Gudiol F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2158-60. PubMed ID: 8540738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
    Arditi M; Mason EO; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL
    Pediatrics; 1998 Nov; 102(5):1087-97. PubMed ID: 9794939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.